Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Lower SHBG levels may increase the risk of PCOS.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Early balding men may have insulin resistance, but lifestyle changes can help.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

An enzyme other than TNAP might be responsible for vitamin B-6 metabolism in the skin.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.